Evidence map›Paper›PMID 35041523›Full record

ArticlemBio2022

Differential Expression of CREM/ICER Isoforms Is Associated with the Spontaneous Control of HIV Infection.

Zhenwu Luo, Min Li, Tai-Wei Li, Zongyang Lv, Zhiwei Ye, William J Cisneros, Jie Zhang, Lingmin Yuan, Judd F Hultquist, Stephen A Migueles and 3 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Zhenwu LuoDepartment of Microbiology and Immunology, Medical University of South Carolinagrid.259828.c, Charleston, South Carolina, USA.
Min LiDepartment of Microbiology and Immunology, Medical University of South Carolinagrid.259828.c, Charleston, South Carolina, USA.
Tai-Wei LiDepartment of Pathology, Ohio State University College of Medicine, Columbus, Ohio, USA.
Zongyang LvDepartment of Biochemistry & Molecular Biology, Hollings Cancer Center, Medical University of South Carolinagrid.259828.c, Charleston, South Carolina, USA.
Zhiwei YeDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolinagrid.259828.c, Charleston, South Carolina, USA.
William J CisnerosDivision of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Jie ZhangDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolinagrid.259828.c, Charleston, South Carolina, USA.
Lingmin YuanDepartment of Biochemistry & Molecular Biology, Hollings Cancer Center, Medical University of South Carolinagrid.259828.c, Charleston, South Carolina, USA.
Judd F HultquistDivision of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Stephen A MiguelesLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Lei HuangDepartment of Microbiology and Immunology, Medical University of South Carolinagrid.259828.c, Charleston, South Carolina, USA.
Jian ZhuDepartment of Pathology, Ohio State University College of Medicine, Columbus, Ohio, USA.
Wei JiangDepartment of Microbiology and Immunology, Medical University of South Carolinagrid.259828.c, Charleston, South Carolina, USA.ORCID 0000-0003-2769-2812
Medical University of South Carolina · USNorthwestern University · USThe Ohio State University · USNational Institutes of Health · US

Funding

X-ray Screening and Rapid Structure DeterminationP50GM082250 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KROGAN, NEVAN J · 2007 to 2018
$48.8M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
Virology and Immunology Technology CoreP30AI117943 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Brian Mustanski · 2015 to 2026
$38.4M
Functionally Defining HIV-Host Interactions During the Early HIV-1 LifecycleR01AI150998 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BIENIASZ, PAUL D., HOPE, THOMAS · 2020 to 2024
$6.8M
Deciphering the Role of CPSF6 in HIV InfectionR01AI165236 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HULTQUIST, JUDD F · 2021 to 2025
$2.0M
Investigation of Latency Promoting Genes (LPGs) in HIV Oral Reservoir CellsR01DE025447 · NIDCR · UNIVERSITY OF ROCHESTER · PI ZHU, JIAN · 2015 to 2019
$1.9M
On the pathogenic role of anti-CD4 antibody in poor CD4+ T cell recovery after antiretroviral therapy in HIV diseaseR01AI128864 · NIAID · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI JIANG, WEI · 2017 to 2021
$1.1M
Role of RNA Methylation in Regulating HIV Proviral ExpressionR56AI157872 · NIAID · OHIO STATE UNIVERSITY · PI ZHU, JIAN · 2021 to 2021
$374k
Role of FACT Proteins in Regulating HIV Transcription and LatencyR01AI150448 · NIAID · OHIO STATE UNIVERSITY · PI ZHU, JIAN · 2019 to 2019
$300k
The Influence of Early Integration Events on HIV Latency and Reactivation PotentialK22AI136691 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HULTQUIST, JUDD F · 2018 to 2019
$269k
NCATS NIH HHS UL1 TR001450NIAID NIH HHS K22 AI136691NIAID NIH HHS P30 AI117943NIAID NIH HHS R01 AI128864NIAID NIH HHS R01 AI150448NIAID NIH HHS R01 AI150998NIAID NIH HHS R01 AI165236NIAID NIH HHS R56 AI157872NIDCR NIH HHS R01 DE025447NIGMS NIH HHS P50 GM082250
6 · The paper itself

Abstract

A rare subset of HIV-infected individuals, termed elite controllers (ECs), can maintain long-term control over HIV replication in the absence of antiretroviral therapy (ART). To elucidate the biological mechanism of resistance to HIV replication at the molecular and cellular levels, we performed RNA sequencing and identified alternative splicing variants from ECs, HIV-infected individuals undergoing ART, ART-naive HIV-infected individuals, and healthy controls. We identified differential gene expression patterns that are specific to ECs and may influence HIV resistance, including alternative RNA splicing and exon usage variants of the CREM/ICER gene (cyclic AMP [cAMP]-responsive element modulator/inducible cAMP early repressors). The knockout and knockdown of specific ICER exons that were found to be upregulated in ECs resulted in significantly increased HIV infection in a CD4

Indexed as

HIV InfectionsCell LineCyclic AMPCyclic AMP Response Element ModulatorHumansProtein IsoformsTranscription FactorsCREM protein, humanCyclic AMPCyclic AMP Response Element ModulatorProtein IsoformsTranscription FactorsCREM/ICER geneelite controllersHIVhost factor

Identifiers

PMID35041523
PMCPMC8725591
OpenAlexW4205679947

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.